Stay updated on IMU-131 HER-Vaxx in HER2+ Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the IMU-131 HER-Vaxx in HER2+ Gastric Cancer Clinical Trial page.

Latest updates to the IMU-131 HER-Vaxx in HER2+ Gastric Cancer Clinical Trial page
- Check3 days agoChange DetectedA new revision label v3.6.2 was added and the previous v3.6.0 removed in the study history. This indicates a newer saved version of the record.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe recruitment status was updated to indicate enrollment has closed, and a new document revision (v3.6.0) was added while the previous revision (v3.5.5) was removed.SummaryDifference0.3%

- Check24 days agoChange DetectedA new revision tag v3.5.5 has been added to the record history. The previous revision v3.5.4 has been removed.SummaryDifference0.1%

- Check46 days agoChange DetectedA new revision entry, v3.5.4, has been added to the study's history to replace the previous v3.5.3, indicating an administrative update to the record. This reflects an update to the documentation rather than any changes to the study content.SummaryDifference0.1%

- Check67 days agoChange DetectedA minor update to the website’s revision/version label was made, changing the displayed revision from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check74 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

Stay in the know with updates to IMU-131 HER-Vaxx in HER2+ Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMU-131 HER-Vaxx in HER2+ Gastric Cancer Clinical Trial page.